Effects Multimodal Mind and Body Approach for MCI
Modulation Effects of a Computer-based Multimodal Mind and Body Approach for Mild Cognitive Decline
1 other identifier
interventional
32
1 country
1
Brief Summary
The aim of this application is to develop a computer-based multimodal mind and body approach (CMMBA) for mild cognitive impairment (MCI). This product will provide a new, cost-effective and easily accessible treatment option for MCI and potentially other age-related dementia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_1
Started Dec 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 11, 2023
CompletedFirst Submitted
Initial submission to the registry
January 27, 2025
CompletedFirst Posted
Study publicly available on registry
February 7, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 11, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 15, 2025
CompletedResults Posted
Study results publicly available
February 2, 2026
CompletedMarch 9, 2026
February 1, 2026
1.3 years
January 27, 2025
January 10, 2026
February 23, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Retention
Proportion of subjects who complete all assessments from the total number of subjects started the first intervention
Through study intervention, an average of three months
Fidelity
session completed of total 30 classes
Through study interventions, an average of three months
Satisfaction to Intervention
average score in a 1-5 scale, 5 indicates very satisfied with the intervention
Through study interventions, an average of three months
Number of Participants With Adverse Events
Adverse events were assessed by participant self-report at each study visit. An adverse event was defined as any unfavorable or unintended sign, symptom, or medical occurrence temporally associated with study participation, regardless of attribution. This outcome reports the number of participants who experienced ≥1 adverse event during the study period (each participant counted once).
Through study interventions, an average of three months
Study Arms (2)
A computer-based multimodal mind and body approach (cbMMBA)
EXPERIMENTALcbMMBA will include three modules: BDJ (module 1), acupressure (module 2), and relaxation techniques including deep breathing, guided imagery, and progressive muscle relaxation
a standard cognitive training
ACTIVE COMPARATORThe program uses paper puzzles (Sudoku, crosswords, word-search, etc.) to engage subjects
Interventions
cbMMBA will include three modules: BDJ, acupressure, and relaxation techniques including deep breathing, guided imagery, and progressive muscle relaxation.
The program uses paper puzzles (Sudoku, crosswords, word-search, etc.) to engage subjects
Eligibility Criteria
You may qualify if:
- report of cognitive decline / complaint by the patient, the patient's informant, or the physician;
- cognitive impairment is confirmed by objective cognitive measures (Montreal Cognitive Assessment (MoCA) and neuropsychological testing), where objective cognitive impairment is defined as poor performance in one or more cognitive measures suggesting deficit in one or more cognitive domains;
- patient has preserved independence in functional abilities (measured by informant report, completion of Activities of Daily Living (ADL) and Instrumental Activities of Daily Living (IADL) checklists);
- not demented;
You may not qualify if:
- has severe visual or hearing impairment;
- has pre-existing musculoskeletal or other conditions, which prohibit BDJ performance and / or the application of acupressure at the selected points;
- has suffered from a neurological disorder (e.g., severe head trauma), psychiatric disease (e.g., major depression), or any other major medical disease that could potentially compromise their cognition;
- has had prior experience with BDJ or acupressure or relaxation techniques in the past year.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Massachusetts General Hospital
Charlestown, Massachusetts, 02129, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Bonnie Wong
- Organization
- MGH
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
January 27, 2025
First Posted
February 7, 2025
Study Start
December 11, 2023
Primary Completion
April 11, 2025
Study Completion
July 15, 2025
Last Updated
March 9, 2026
Results First Posted
February 2, 2026
Record last verified: 2026-02